Moonshot AI raised $3.5 billion at a $35 billion valuation, reported by Bloomberg on July 29, tripling its value in six months and nearly doubling its initial fundraising target. The round was anchored by China’s National Artificial Intelligence Industry Investment Fund — the same state-backed vehicle negotiating to become lead investor in DeepSeek’s first-ever external funding round. That convergence transforms Moonshot’s latest capital injection from a market event into a state signal: Beijing is building an entire tier of frontier AI labs, not picking one winner.
The catalyst was Kimi K3. Moonshot’s flagship 2.8 trillion-parameter model debuted on July 16 and has since driven a sixfold surge in the company’s daily sales, according to Bloomberg. The open-weights release on July 26-27 — a day ahead of schedule — expanded K3’s reach into the global developer ecosystem. Within days, open-weight Chinese models captured 68 percent of observed token volume in the open-weight segment, according to secondary tracking. Mozilla’s CTO personally adopted the model. The Trump administration reportedly revived its push to ban Chinese AI models, but officials privately acknowledged that downloadable open weights could make an outright US ban nearly impossible to enforce.
Moonshot’s fundraising trajectory tells its own acceleration story. In January 2026, the company closed a $700 million round at a $10 billion valuation, anchored by state-backed capital with Alibaba as a co-investor. In May, it raised $1 billion at an $18 billion valuation. Now, just two months later, the latest round values the company at $35 billion — a 3.5x increase from the start of the year. Bloomberg reports that Moonshot is already in talks to raise new funds at a $50 billion pre-money valuation and is considering a Hong Kong IPO as soon as late 2026.
The state architecture behind these rounds is increasingly visible. China’s National AI Industry Investment Fund, established in January 2025 with approximately $8.8 billion in capital backed by the government’s semiconductor investment vehicle, is now simultaneously anchoring Moonshot at $35 billion and negotiating to become lead investor in DeepSeek’s IPO-track fundraising at a valuation of up to $50 billion. Between them, the two largest Chinese frontier labs are being consolidated with state-directed capital at a combined valuation approaching $85 billion. This is not competitive market dynamics — it is industrial policy for frontier AI.
The policy scaffolding extends beyond investment. In April 2026, China’s National Development and Reform Commission quietly instructed Moonshot, ByteDance, and StepFun to reject US-origin capital without explicit government approval, Bloomberg reported. The NDRC guidance, which came after Meta’s reported deal with Manus AI, signaled Beijing’s intent to keep American money out of strategically sensitive AI companies. The US reciprocal stance — banning its own investors from backing Chinese AI and chip companies since January 2025 — means both capitals are now formally excluded from the other’s frontier AI ecosystem.
Yet Moonshot faces unresolved headwinds. The Bureau of Industry and Security is investigating the company over allegations of acquiring NVIDIA GB300 chips through Thailand and distilling Anthropic’s Fable model — the same allegations referenced in the White House’s AI policy framework. The entity-list consideration was shelved after internal pushback, according to Axios, but the investigation remains active. If the company proceeds with a Hong Kong IPO at or above its current valuation, those unresolved regulatory risks become investor disclosure requirements.
The tension between Moonshot’s momentum and its regulatory exposure is the defining dynamic of the moment. The same week the company closed its largest round, open-weight Chinese models captured a dominant share of global token volume, the US Congress was debating the Kill Switch Act, and Anthropic’s CEO was calling for a ban on selling powerful chips to China. The $35 billion valuation prices in none of these risks — or, more precisely, prices in the assumption that state-backed capital and domestic demand are sufficient insulation from US regulatory action.
What Moonshot’s round actually demonstrates is that the open-weights release strategy — shipping capable models for global download before regulators can act — has become a fundraising accelerant. Kimi K3’s sixfold sales surge did not come from enterprise contracts or government procurement. It came from developer adoption and API demand generated by a model released into the wild. Beijing’s willingness to anchor a $35 billion valuation on the strength of that momentum signals a calculation that global adoption, not US approval, will determine which frontier labs survive the next phase of the AI race.